Skip to content
Last sale
Nov 6, 2026 · +11.04%
Market cap
$323.06M
45.25M shares
Filings
1,047
$31.49M
Q3 2026+10.4% FY25 yoy
$2.73M
Q3 2026N/M FY25 yoy
$11.41M
Q3 2026N/M FY25 yoy
-$87.24M
Q3 2026derivedN/M FY25 yoy
$0.02
Q3 2026N/M FY25 yoy
$66.94M
Q3 2026−92.6% FY25 yoy
$323.06M
10.5×
2.4×
—
-32.15%
—

Twelve months to Sep 30, 2026 · derived

Price

$7.14+93.50%+$3.45past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$114.20MFY 2025
$295.67M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$114,196,000reported
FY 20242024-12-31$103,463,000reported
FY 20232023-12-31$156,314,000reported
FY 20222022-12-31$98,024,000reported
FY 20212021-12-31$295,665,000reported
FY 20202020-12-31$88,170,000reported
FY 20192019-12-31$150,048,000reported
FY 20182018-12-31$36,784,000reported
FY 20172017-12-31$42,877,000reported
FY 20162016-12-31$22,573,303reported
FY 20152015-12-31$24,817,025reported
FY 20142014-12-31$6,977,455reported

Capital returns

Dividends and buybacks · FY2009 to FY2023
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$606.00K$606.00K—418.92M sh+26.0%—
FY2011—$0.00$0.00—22.49M sh——
FY2010—$0.00$0.00————
FY2009—$54.94K$54.94K————

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $32.78MRest of World · FY2018 · $4.00MRest of World · FY2018 · $4.00MFY2019United States · FY2019 · $149.36MRest of World · FY2019 · $690.00KRest of World · FY2019 · $690.00KFY2020United States · FY2020 · $83.55MRest of World · FY2020 · $4.62MRest of World · FY2020 · $4.62MFY2021United States · FY2021 · $288.96MRest of World · FY2021 · $6.70MRest of World · FY2021 · $6.70MFY2022United States · FY2022 · $87.51MRest of World · FY2022 · $10.51MRest of World · FY2022 · $10.51MFY2023United States · FY2023 · $153.34MRest of World · FY2023 · $2.98MRest of World · FY2023 · $2.98MFY2024United States · FY2024 · $101.46MRest of World · FY2024 · $2.00MRest of World · FY2024 · $2.00MFY2025United States · FY2025 · $113.16MRest of World · FY2025 · $1.04M
LineFY2025ShareChange
United States$113.16M99%+11.5%
Rest of World$1.04M0.9%−48.3%
Rest of World———
Total$114.20M

From the 10-K filed Mar 16, 2026AGEN

Biological products, except diagnostic substances

Agenus Inc is the 28th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Agenus Inc · CIK 1098972 · Engraved from SEC EDGAR